[1] 朱美美,汪闿智,朱艳艳,等.首发未用药精神分裂症病人壳核及伏隔核静息态功能连接的研究[J].国际医学放射学杂志,2022,45(2):125-129. [2] 赵文青.支持性-表达性团体心理干预联合棕榈酸帕利哌酮治疗急性期首发精神分裂症患者的临床疗效[J].医学临床研究,2022,39(5):690-692. [3] 侯思伟,曹静钰,刘承梅,等.个案管理对HIV/AIDS患者治疗依从性和疗效的Meta分析[J].护士进修杂志,2022,37(10):880-885. [4] SISKIND D, ORR S, SINHA S,et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis[J].Br J Psychiatry,2022,220(3):115-120. [5] JOO J Y, LIU M F. Understanding nurse-led case management in patients with chronic illnesses: a realist review[J].West J Nurs Res,2021,43(2):182-195. [6] 朱峰,贾敏,马青艳,等.精神分裂症患者血清炎症因子变化与临床症状及认知功能的相关性[J].西安交通大学学报(医学版),2021,42(2):301-305. [7] 苗天翼,闫军锋,苏琦,等.氨磺必利联合高压氧对精神分裂症患者述情障碍及血液流变学的影响[J].医学临床研究,2022,39(11):1669-1671. [8] CAMPEAU A, MILLS R H, STEVENS T,et al. Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia[J].Mol Psychiatry,2022,27(2):1217-1225. [9] 张思宇,周郁秋,王正君,等. 精神分裂症超高危人群的早期心理干预与精神分裂症转化关系的Meta分析[J].中国心理卫生杂志,2021,35(4):290-299. [10] LÄHTEENVUO M, TIIHONEN J. Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations[J].Drugs,2021,81(11):1273-1284. [11] 黄丽丽.个案管理模式对精神分裂症患者康复效果及生活质量的影响[J].黑龙江医学,2023,47(10):1240-1242. [12] 王倩云,厉春林,张雅芝,等.护士个案管理师角色体验的质性研究Meta整合[J].解放军护理杂志,2022,39(7):79-82. [13] SCHILLER C, GRÜNZIG M, HEINRICH S, et al. Case management for people with dementia living at home and their informal caregivers: a scoping review[J].Health Soc Care Community,2022,30(4):1233-1253.
2024, Vol. 41 
